ImmunoPrecise Antibodies Ltd.
IPA
$0.3918
-$0.0082-2.05%
| 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.87M | -2.92M | -13.30M | -2.18M | -1.78M |
| Total Depreciation and Amortization | 1.02M | 1.01M | 1.14M | 953.30K | 996.30K |
| Total Amortization of Deferred Charges | 13.20K | 12.40K | 25.80K | 16.30K | -- |
| Total Other Non-Cash Items | -55.70K | -235.20K | 10.32M | 48.10K | 28.00K |
| Change in Net Operating Assets | -753.60K | 804.80K | -128.20K | 665.90K | 737.90K |
| Cash from Operations | -1.64M | -1.33M | -1.95M | -493.30K | -13.30K |
| Capital Expenditure | -47.60K | -192.10K | -830.50K | 122.20K | -220.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 11.80K | -80.00K | -9.60K |
| Cash from Investing | -47.60K | -192.10K | -818.80K | 42.20K | -229.80K |
| Total Debt Issued | 1.46M | 2.60M | -- | -- | -- |
| Total Debt Repaid | -407.00K | -394.00K | -302.00K | -322.00K | -310.00K |
| Issuance of Common Stock | 1.02M | 491.00K | 1.43M | 935.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.52M | 1.97M | 827.60K | 454.00K | -228.30K |
| Foreign Exchange rate Adjustments | -102.50K | -112.50K | -83.30K | 134.10K | -50.80K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -277.60K | 332.30K | -2.02M | 137.00K | -522.10K |
